AINOSTICS featured in Frost & Sullivan market report
AINOSTICS is highlighted in a recent Radar report by Frost & Sullivan, titled "Neuroimaging Technology Advances and Growth...
AINOSTICS featured in Frost & Sullivan market report
AINOSTICS selected for the Texas Medical Centre Accelerator Programme
AINOSTICS at RSNA 2022
Prolific North Tech Award
AINOSTICS granted FDA Breakthrough Device Designation
NIHR funded clinical pilot
AINOSTICS CEO awarded prestigious Future Leaders Fellowship by UKRI
Mayor's International Business Programme
AINOSTICS secures $2,600,000
AICon 2021